Australia's largest stock trading and investment forum Australia's #1 stock forum

RXL

Click for more information

3.33%

15.5¢ rox resources limited

Welcome new Rox holders via Venus, page-19

First 19 Last

Share
Profile

Follow
m0ngy

10,075 Posts.

4852

20/07/23

09:23

Post #: 68880057
Share

Originally posted by CashedUpBogun: ↑

that is 100% false assuming all 3.2moz are economical to mine.

the scoping study was flawed and is a scoping study not a feasibility study.

the deposit as a reminder to all is refractory - processing using floatation is a potential recovery method, however to date in Australia the only gold project using it successfully are SLR's deflector.

Deflector is higher grade than Youanmi and has silver and copper credits. Copper is the reason that processing route was taken. Youanmi have no credits, only arsenic as a penalty metal. And now Wiluna are talking about going back to Biox and they have 6moz.

compared to peer exploration teams like GBR and GCY this team moves slowly and lacks critical information in announcements such as sections and core photos. Their lab turn-around is shockingly slow. First class exploration team I think not.

Searching for another Penny rather than building on your existing resource for that critical mass required for project development is a pivot away from the narrative the company have been spruking.

Be careful with this one - the only other refractory gold project close to development is DEG's Hemi - and that is a monster. There are better opportunities in gold out there than RXL

Expand

RXL Price at posting: 27.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

VMM

Virdis Mining flags breakthrough with 76% neodymium and praseodymium recoveries

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

There are more pages in this discussion • 12 more messages in this thread...

First 19 Last

Add RXL (ASX) to my watchlist

(20min delay)
Last 15.5¢		Change 0.005(3.33%)		Mkt cap ! $63.12M

Open	High	Low	Value	Volume
15.5¢	15.5¢	15.0¢	$171.5K	1.118M

Buyers (Bids)

No.	Vol.	Price($)
5	123464	14.5¢

Sellers (Offers)

Price($)	Vol.	No.
15.5¢	62288	2

View Market Depth

No.	Vol.	Price($)
5	123464	0.145
5	361765	0.140
6	209673	0.135
8	858363	0.130
7	357334	0.125

Price($)	Vol.	No.
0.155	62288	2
0.160	129916	3
0.165	31495	4
0.170	37421	3
0.175	33844	4

Last trade - 14.20pm 17/07/2024 (20 minute delay)

RXL (ASX) Chart